Psychosocial, mental and suboptimal health measures are not affected by provision of abdominal aortic calcification imaging results: a 12-week RCT
Introduction:The provision of abdominal aortic calcification (AAC) imaging results can elicit cardiovascular disease (CVD)-risk reducing behaviours.However, its impact on psychosocial, mental and suboptimal health measures is less clear.Methods: Secondary analyses of a previously reported 12-week, single-blind, randomised controlled trial (RCT) including 240 community-dwelling older Australian men and women.Participants were provided with AAC imaging results and CVD risk-reducing educational resources (AAC+Ed, n=121) or education alone (Control+Ed, n=119).Psychosocial distress, mental health score and suboptimal health status were estimated using validated questionnaires.Linear mixed models were used to compare changes between groups across 12 weeks.Results: 240 participants (mean SD, age 67.8 5.0 years, 57.5% females) were randomised and 227 (95%) completed the study.Approximately 57% had evidence of AAC (1 on a 24point scale) at baseline.Providing AAC imaging results to older men and women did not affect psychosocial health, mental health and suboptimal health (all p>0.05) measures compared to Control+Ed.The mean net differences for change (95%CI) for depression, anxiety and stress were -0.50 (-1.42, 0.42), -0.20 (-0.81, 0.41) and -0.21 (-1.18, 0.76), respectively; the mean net difference for change (95%CI) for mental health component score was 1.69 (-1.29, 4.67) and for total suboptimal health status was -0.84 (-2.08, 0.39). Conclusions:In older men and women, the provision of AAC results with education on CVD risk factors did not alter measures of psychosocial, mental, and suboptimal health status over 12 weeks compared to education alone.The study was registered at www.anzctr.org.
Authors
- Richard John Woodman (ORCID: https://orcid.org/0000-0002-4094-1222)
- Catherine P. Bondonno (ORCID: https://orcid.org/0000-0001-8509-439X)
- Lauren C. Blekkenhorst (ORCID: https://orcid.org/0000-0003-1561-9052)
- Markus Peter Schlaich (ORCID: https://orcid.org/0000-0002-1765-0195)
- Simone Radavelli‐Bagatini (ORCID: https://orcid.org/0000-0001-6821-5217)
- Wai H. Lim
- Jack Dalla Via
- Jonathan M. Hodgson
- Amanda Devine (ORCID: https://orcid.org/0000-0001-6978-6249)
- Robin M. Daly (ORCID: https://orcid.org/0000-0002-9897-1598)
- Wei Wang
- Moira Sim (ORCID: https://orcid.org/0000-0001-5962-6639)
- Abadi K. Gebre
- Kun Zhu
- Ben Jackson
- John T. Schousboe (ORCID: https://orcid.org/0000-0002-9329-0750)
- Joshua R. Lewis (ORCID: https://orcid.org/0000-0003-1003-8443)
- James Dimmock (ORCID: https://orcid.org/0000-0002-4475-8169)
- Pawel Szulc
- Marc Sim
- Douglas P. Kiel (ORCID: https://orcid.org/0000-0001-8474-0310)
Institutions
- Université Claude Bernard Lyon 1 (FR)
- Edith Cowan University (AU)
- University of Minnesota (US)
- Beth Israel Deaconess Medical Center (US)
- Harvard University (US)
- Deakin University (AU)
- Inserm (FR)
- Flinders University (AU)
- The Kids Research Institute Australia (AU)
- The University of Western Australia (AU)
- Royal Perth Hospital (AU)
- Sir Charles Gairdner Hospital (AU)
- Hospices Civils de Lyon (FR)
- Park Nicollet Clinic (US)
- Hebrew SeniorLife (US)
- HealthPartners (US)
- James Cook University (AU)
Publication Details
- Journal
- AJPM Focus
- Published
- 2026-05-01
- DOI
- https://doi.org/10.1016/j.focus.2026.100507
- Primary Topic
- Parathyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Royal Perth Hospital Medical Research Foundation
- National Heart Foundation of Australia
- National Health and Medical Research Council
- Western Australian Future Health and Innovation Fund, Government of Western Australia